Skip to content

TRANSEND 300 ES GUIDEWIRE - 46-814

by Boston Scientific, Target

510(k) K022357

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK022357 Date16 Oct 2002ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Transend 300 ES Guidewire (Model 46-814) and Transend 300 Floppy Guidewire (Model 46-815) are intravascular guidewires designed for use in neuro and peripheral vasculature. Both feature a 0.014-inch diameter and a length of 300 cm, enabling precise navigation and exchange of therapeutic devices without requiring extension wires. The ES model incorporates enhanced stiffness for directional control, while the Floppy model offers greater flexibility for delicate vascular access.

These guidewires are intended for clinical use in catheterization laboratories and interventional settings. Supplied sterile and intended for single-use, they are compatible with standard manual torque devices for directional manipulation. The devices are regulated under FDA 510(k) clearance (K022357) and fall under the Product Code DQX classification, with a review by the Cardiovascular Advisory Committee. Storage and handling must adhere to sterile medical device protocols.

Other devices from Boston Scientific, Target

See all devices from Boston Scientific, Target →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary difference between the Transend 300 ES Guidewire and the Transend 300 Floppy Guidewire in terms of clinical use?

    The Transend 300 ES Guidewire (Model 46-814) is designed with enhanced stiffness for better directional control, making it ideal for precise navigation in neuro and peripheral vasculature where controlled advancement is critical. In contrast, the Transend 300 Floppy Guidewire (Model 46-815) offers greater flexibility, which is beneficial for delicate vascular access or when navigating tortuous anatomy without requiring extension wires.

  • Are these guidewires compatible with standard manual torque devices, and why might that matter?

    Yes, both the Transend 300 ES and Floppy Guidewires are compatible with standard manual torque devices. This compatibility is important because it allows clinicians to manipulate the guidewire effectively for directional control during procedures, ensuring smoother catheter exchange and navigation in complex vascular pathways.

  • How should these guidewires be stored, and what does the single-use designation imply for clinical workflow?

    These guidewires are supplied sterile and must be stored following standard sterile medical device protocols to maintain integrity. The single-use designation implies they are not intended for reuse, which helps prevent cross-contamination and ensures consistent performance for each procedure, reducing the risk of complications associated with reprocessed devices.

  • What are the key dimensions of these guidewires, and how do they support their intended use?

    Both guidewires have a uniform diameter of 0.014 inches and a length of 300 cm, which allows for precise navigation through both neuro and peripheral vasculature. The length eliminates the need for extension wires, while the diameter ensures compatibility with standard catheters and interventional tools, making them versatile for a range of clinical scenarios.

  • What regulatory pathway was followed for these devices, and what does that mean for clinicians?

    The Transend 300 ES and Floppy Guidewires were cleared through the FDA’s 510(k) process (K022357) with a determination of substantial equivalence, reviewed by the Cardiovascular Advisory Committee. This means the devices were evaluated against a legally marketed predicate and deemed to have similar intended use and technological characteristics, providing clinicians with confidence in their safety and performance for neuro and peripheral vascular procedures.